Thromb Haemost 1964; 12(02): 391-395
DOI: 10.1055/s-0038-1655553
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

On the Combined Administration of Streptokinase and Pancreatic Trypsin Inhibitor

M Verstraete
1   Laboratory of Coagulation and Proteolysis Department of Medicine, University of Louvain, Belgium
,
J Vermylen
1   Laboratory of Coagulation and Proteolysis Department of Medicine, University of Louvain, Belgium
,
C Vermylen
1   Laboratory of Coagulation and Proteolysis Department of Medicine, University of Louvain, Belgium
,
R. A De Vreker
1   Laboratory of Coagulation and Proteolysis Department of Medicine, University of Louvain, Belgium
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. Juni 2018 (online)

Preview

Summary

Preliminary results on the modification of blood fibrinogen level and plasma plasminogen value and fibrinolytic activity during combined administration of streptokinase and pancreatic trypsin inhibitor are presented. Not only fibrinogen fall but also plasminogen depletion is inhibited.